Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Open-market sale Chief Financial Officer sold 7,942 shares at $31.51 ($250,252)
  2. 4 Open-market sale SVP, Chief Accounting Officer sold 64 shares at $29.17 ($1,867)
  3. 4 Open-market sale EVP and Chief Legal Officer sold 2,450 shares at $31.17 ($76,367)
  4. 4 Open-market sale SVP, Chief Accounting Officer sold 84 shares at $31.39 ($2,637)
  5. 4 Planned sale Director sold 2,405 shares at $37.39 ($89,923)
  6. 4 Grant or award Director acquired 5,740 shares (grant or award)
  7. 4 Grant or award Director acquired 5,740 shares (grant or award)
  8. 4 Grant or award Director acquired 5,740 shares (grant or award)
  9. 4 Grant or award Director acquired 5,740 shares (grant or award)
  10. 4 Grant or award Director acquired 5,740 shares (grant or award)
  11. 4 Grant or award Director acquired 5,740 shares (grant or award)
  12. 4 Grant or award Director acquired 5,740 shares (grant or award)
  13. 4 Open-market sale EVP and Chief Medical Officer sold 762 shares at an average $37.93 ($28,901)
  14. 4 Open-market sale Chief Financial Officer sold 1,785 shares at $40.40 ($72,114)
  15. 4 Open-market sale CBO & EVP sold 6,028 shares at $42.10 ($253,779)
  16. 4 Open-market sale EVP and Chief Legal Officer sold 12,846 shares at $42.10 ($540,817)
  17. 4 Open-market sale EVP and Chief Medical Officer sold 8,945 shares at $42.10 ($376,585)
  18. 4 Open-market sale Pinion John Richard sold 14,439 shares at $42.10 ($607,882)
  19. 4 Planned sale President & CEO sold 98,434 shares at an average $42.20 ($4,153,571)
  20. 4 Open-market sale EVP & Chief Commercial Officer sold 15,103 shares at $42.10 ($635,836)

Page 3 of 32 · 627 filings